A Comparison of Inhaled Ipratropium, Oral Theophylline Plus Inhaled β-Agonist, and the Combination of All Three in Patients With COPD-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Comparison of Inhaled Ipratropium, Oral Theophylline Plus Inhaled β-Agonist, and the Combination of All Three in Patients With COPD

Published:1994-04 Issue:4 Volume:105 Page:1089-1094
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Karpel Jill P.,Kotch Arthur,Zinny Miguel,Pesin Jeffrey,Alleyne William

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference15 articles.

1. The effect of atropine inhalation in ‘irreversible’ chronic bronchitis?;Marini;Chest,1980

2. A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium) bromide), given by aerosol alone or in combination?;Easton;N Engl J Med,1986

3. Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease: a 90-day multi-center trial?;Taskin;Am J Med,1986

4. A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD?;Karpel;Chest,1990

5. Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPD?;Karpel;Chest,1991

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in China;Therapeutic Advances in Respiratory Disease;2019-01

2. Current Pharmacotherapy for COPD;Indacaterol;2013-10-16

3. Prise en charge thérapeutique de l’atteinte des voies aériennes distales dans la BPCO;Revue des Maladies Respiratoires;2011-12

4. Co-deposition of a triple therapy drug formulation for the treatment of chronic obstructive pulmonary disease using solution-based pressurised metered dose inhalers;Journal of Pharmacy and Pharmacology;2011-10-27

5. Management Guidelines for Chronic Obstructive Pulmonary Disease;COPD;2010-10-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3